Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)
Trial details
- Registry ID
- NCT04270682
- Phase
- Phase 3
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study to Evaluate Patients With Cerebrotendinous Xanthomatosis (RESTORE)NCT04270682 | MIRM | Phase 3 | Completed | 2023-07-13Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |